logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.

    • Serotonin Reuptake Inhibitor class drugs

    FiltersReset Filters
    15 results

    • fluoxetine

      (Fluoxetine Hydrochloride)
      Aurobindo Pharma Limited
      Usage: Fluoxetine capsules are indicated for the treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. In combination with Olanzapine, they also treat depressive episodes in Bipolar I Disorder and treatment-resistant depression. Monotherapy with fluoxetine is not approved for Bipolar I or treatment-resistant depression.

    • fluoxetine

      (Fluoxetine Hydrochloride)
      ScieGen Pharmaceuticals, Inc.
      Usage: Fluoxetine is indicated for the treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. In combination with Olanzapine, it is used for depressive episodes in Bipolar I Disorder and treatment-resistant depression. Monotherapy with fluoxetine is not suitable for these latter conditions.

    • fluoxetine hydrochloride

      (Fluoxetine Hydrochloride)
      ANI Pharmaceuticals, Inc.
      Usage: Fluoxetine is indicated for the acute and maintenance treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. It is not approved for Bipolar I Disorder depressive episodes or treatment-resistant depression.

    • fluvoxamine maleate

      (Fluvoxamine maleate)
      Upsher-Smith Laboratories, LLC
      Usage: Fluvoxamine maleate tablets are indicated for treating obsessive-compulsive disorder (OCD), addressing distressing obsessions and compulsions that interfere with daily functioning. Efficacy has been established through multiple clinical trials in both adult and pediatric populations.

    • fluvoxamine maleate

      (Fluvoxamine Maleate)
      Ajanta Pharma USA Inc.
      Usage: Fluvoxamine maleate extended-release capsules are indicated for treating obsessive-compulsive disorder (OCD) in adults and children (ages 8-17). The drug addresses recurrent, distressing obsessions and compulsions that interfere with daily functioning, evidenced by clinical trials demonstrating efficacy over both short and long-term use.

    • lexapro

      (ESCITALOPRAM)
      Allergan, Inc.
      Usage: Lexapro is indicated for treating major depressive disorder (MDD) in adults and pediatric patients aged 12 and older, as well as generalized anxiety disorder (GAD) in adults and pediatric patients aged 7 and older.

    • paroxetine

      (PAROXETINE)
      Chartwell RX, LLC.
      Usage: Paroxetine is indicated for the treatment of major depressive disorder, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder in adults.

    • paroxetine

      (Paroxetine)
      Yiling Pharmaceutical, Inc.
      Usage: Paroxetine is indicated for treating major depressive disorder, obsessive compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder in adults.

    • prozac

      (Fluoxetine hydrochloride)
      Dista Products Company
      Usage: PROZAC® is indicated for the treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. It is also used in combination with Olanzapine for Bipolar I Disorder and treatment-resistant depression in patients unresponsive to previous antidepressants.

    • sertraline hydrochloride

      (Sertraline hydrochloride)
      Granules Pharmaceuticals Inc.
      Usage: Sertraline hydrochloride tablets are indicated for treating major depressive disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, social anxiety disorder, and premenstrual dysphoric disorder.